ArticleNeurochemical research2026
Effects of tDCS on Cognitive Function in MCAO/R Rats by Regulating Mitochondrial Autophagy Mediated by the PINK1/Parkin Signaling Pathway.
Article in Neurochemical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Cognitive dysfunction is a common and disabling consequence of stroke. Transcranial direct current stimulation (tDCS), a non-invasive neuromodulation technique, has shown promise in rehabilitation; however, its molecular mechanisms remain unclear, and the lack of standardized stimulation parameters limits its clinical application. This study aimed to investigate the effects of tDCS with different intensities on cognitive function in rats subjected to middle cerebral artery occlusion/reperfusion (MCAO/R) and to elucidate the underlying mechanisms. A male Sprague-Dawley rat MCAO/R model was established, and animals were treated with varying intensities of anodal tDCS (a-tDCS). Cognitive function was assessed using the Morris water maze and a novel object recognition test, while neurological deficits were evaluated through neurological scoring and 2,3,5-triphenyltetrazolium chloride staining. Mitochondrial autophagy was examined by transmission electron microscopy, and the expression of PINK1/Parkin-mediated autophagy pathway proteins was analyzed by Western blot and immunohistochemistry. The results showed that 0.2 mA medium-intensity a-tDCS produced the most significant therapeutic effect, alleviating mitochondrial damage, reducing excessive mitochondrial accumulation, and attenuating neuronal apoptosis. Mechanistically, these effects were associated with activation of the PINK1/Parkin pathway, ultimately leading to improved learning and memory function. Mechanistically, these effects were associated with PINK1/Parkin pathway activation, and were attenuated when PINK1 was knocked down. Medium-intensity a-tDCS exerts neuroprotective effects in MCAO/R rats by enhancing mitophagy through the PINK1/Parkin signaling pathway, which providing a potential experimental basis for optimizing clinical rehabilitation strategies.
Indexed as
Identifiers
41824147What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.